Native Bacterial and Viral Antigens Market Analysis 2031
Native Bacterial and Viral Antigens Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 17.11 Million |
Market Size by 2027 | US$ 28.8 Million |
Global CAGR (2019 - 2027) | 6.8% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Native Bacterial and Viral Antigens Market – byProduct Type
- Chlamydia Antigens ?
- Adenovirus Antigens
- Borrelia Antigens
- Chikungunya Virus Antigens
- Clostridium Antigens
- Dengue Virus Antigens
Native Bacterial and Viral Antigens Market – by Pathogen Type
- Inactivated Pathogen
- Purified Pathogen
Native Bacterial and Viral Antigens Market – by Application
- ELISA
- Immunoassay
- SDS-PAGE
- Hemagglutination
- Agglutination Test
Native Bacterial and Viral Antigens Market – by EndUser
- Diagnostic Laboratories and Centers
- Academic and Research Institutes
Native Bacterial and Viral Antigens Market– by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- BIO-RAD LABORATORIES INC.
- Microbix Biosystems
- SERION Immunologics
- Aalto Bio Reagents Ltd
- Enzo Life Sciences Inc.
- Jena Bioscience GmbH
- ROSS SOUTHERN LABORATORIES
- The Native Antigen Company
- Creative Diagnostics
- TRINA BIOREACTIVES AG